What is polymorphism? Which instruments are used to measure polymorphism of both API and excipients?

Given:
Height ($h$) = $60 \text{ cm}$
Diameter ($D$) = $85 \text{ cm}$
The radius ($r$) is half of the diameter: $r = \frac{D}{2}$.
The formula for the angle of repose ($\theta$) is: $\tan \theta = \frac{h}{r}$.

The angle of repose is $\boxed{\mathbf{54.68^\circ}}$.

A. III. Can you proceed to formulation studies based on answer in (i)? Support your answer.
No, it is not advisable to proceed directly to formulation studies with an angle of repose of $54.68^\circ$. An angle of repose greater than $40^\circ$ generally indicates poor to very poor flow properties. Such poor flow can lead to significant problems during manufacturing, including non-uniform die filling, inconsistent tablet or capsule weights, and segregation of active pharmaceutical ingredients (APIs) from excipients, all of which compromise product quality and manufacturing efficiency.

A. IV. What strategies can be employed to improve angle of repose?
Strategies to improve the angle of repose (and thus powder flow) include:

• Granulation: Converting fine powders into larger, more uniform granules (e.g., wet granulation, dry granulation).
• Addition of glidants: Incorporating flow enhancers such as colloidal silicon dioxide or talc.
• Particle size and shape modification: Optimizing particle size distribution (e.g., reducing fines) and achieving more spherical particles.
• Controlling moisture content: Ensuring optimal moisture levels, as both excessive and insufficient moisture can impair flow.

B. a) What is the polymorphic structure in Figure 1.2 and Figure 1.3, respectively?

• Figure 1.2: This represents a crystalline structure, characterized by a highly ordered and regular arrangement of particles.
• Figure 1.3: This represents an amorphous structure, characterized by a disordered and irregular arrangement of particles.

B. b) Which structure will be appropriate for sustained release dosage form and immediate release dosage form? Support your answer.

• For a sustained release dosage form: The crystalline structure (Figure 1.2) is more appropriate. Crystalline forms typically have lower solubility and slower dissolution rates due to their stable, ordered lattice structure, which leads to a prolonged and controlled release of the drug.
• For an immediate release dosage form: The amorphous structure (Figure 1.3) is more appropriate. Amorphous forms generally exhibit higher solubility and faster dissolution rates because their disordered arrangement requires less energy to break intermolecular bonds, allowing for rapid drug release and absorption.

B. c) What is polymorphism?
Polymorphism is the ability of a solid material to exist in more than one crystal structure or amorphous form. These different forms, known as polymorphs, have the same chemical composition but possess distinct physical properties such as solubility, melting point, density, and dissolution rate.

B. d) Which instruments are used to measure polymorphism of both API and excipients?
Common instruments used to measure polymorphism include:

• X-ray Diffraction (XRD): To identify and quantify different crystalline forms.
• Differential Scanning Calorimetry (DSC): To detect phase transitions, melting points, and glass transition temperatures.
• Fourier-Transform Infrared (FTIR) Spectroscopy or Raman Spectroscopy: To identify differences in molecular vibrations due to different crystal packing.
• Hot Stage Microscopy: To visually observe changes in crystal morphology and phase transitions upon heating.

C. Figure 1.4 represent Friability tests of Ibuprofen tablets.
Figure 1.4 is not provided in the image, so I cannot answer any questions related to it.